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INTRODUCTION
Multiple symmetric lipomatosis (MSL) (syn.: Lau-
nois Bençaude Syndrome, Morbus Madelung, benign 
symmetric lipomatosis) was first described in 1846 by 
Brodie and is defined as a symmetric disorder of nonen-
capsulated adipose tissue growth.1 In 1888, Madelung 
reported on 3 patients with symmetrical submental de-
positions of fat, the “Madelung’s collar,” and in 1898, 
Launois and Bençaude described the phenotype as 
“symmetrical adenolipomatosis.” Its prevalence is in-
dicated as 1:25,000 and affects, as stated in the litera-
ture, mainly Mediterranean males (male: female ratio 
of 15–30:1).2–6
Diagnosis is established through physical examination 
and anamnesis. There are principally 2 different classifica-
tions used in the literature. Enzi et al. (E)1 described 2 
types of anatomic distribution of fat deposits. Type 1 (E) 
is predominantly distributed in the neck (Madelung’s col-
lar), shoulders, supraclavicular triangle, and proximal up-
per limbs. In type 2 (E), the neck area and upper trunk are 
not affected; deposits occur in the abdomen and thighs.1 
The most common classification was described in 1991 by 
Donhauser (D) and divides patients into 4 types of MSL,7 
as shown in Table 1.
The pathophysiology of MSL still remains unclear, 
although several approaches have been described. An as-
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Background: Multiple symmetric lipomatosis (MSL) is defined as a disorder of 
nonencapsulated adipose tissue growth. Its prevalence is indicated as 1:25,000 
and affects, as stated in the literature, mainly Mediterranean males (male:female 
ratio of 15:1). Phenotypes are still classified as defined by Donhauser in 1991. We 
report clinical and phenotypic data of the largest patient cohort investigated in 
Germany so far.
Methods: Forty-five patients diagnosed with MSL at the University Hospital Regens-
burg between 2007 and 2017 were photographed, clinically examined, and blood 
samples were taken. Based on the photographs (n = 33), 11 independent observers 
assessed patients using the Donhauser classification. Furthermore, the bodies of 
all patients were subdivided into 12 body areas, and the viewers had to indicate all 
MSL-affected areas per patient. Prevalence was calculated, comorbidities were as-
sessed, and blood samples were analyzed.
Results: According to the established Donhauser classification, less than 50% of 
the patients could be classified. Therefore, based on the constellations of MSL-
affected body areas, a new classification that divides phenotypes of MSL into 5 
types (Ia, Ib, Ic, II, and III) was set up and was able to cover 100% of our patients. 
The male to female ratio was found to be 1:2.5 (male:female). Prevalence of MSL 
in the catchment area was found to be 1:25,000. Hypercholesterinemia and hypo-
thyroidism were frequent comorbidities, and blood analyses were normal besides 
a hypercholesterinemia.
Discussion: The new proposed classification system describes 5 subtypes and al-
lowed to classify all assessed patients. Male to female ratio (1:2.5) contradicted most 
previous publications. (Plast Reconstr Surg Glob Open 2018;6:e1722; doi: 10.1097/
GOX.0000000000001722; Published online 4 April 2018.)
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sociation with hyperinsulinemia, hyperlipoproteinemia, 
hypothyroidism, hyperuricemia, renal tubular acidosis, 
neuropathy, and myopathy has been described.8–13 Neuro-
logical multisystem manifestation is common in these pa-
tients but cannot be solely explained by alcohol abuse.14,15 
Quite generally, the association between alcohol con-
sumption and MSL is a controversial issue.3,14,16 Reports 
of sudden death and autonomous nervous affection have 
expanded the list of possible related diseases and compli-
cations.15
There are only a few reports of familiar MSL cases that 
indicate a monogenetic cause that is inherited in an au-
tosomal dominant manner.17 A mitochondrial disorder, 
myoclonic epilepsy with ragged red fibers syndrome, is 
often associated with lipomatosis, although a correlated 
gene mutation has not been discovered.15
The purpose of the present study was to investigate the 
largest German cohort of MSL patients (n = 45) treated at 
the University Hospital Regensburg and to obtain further 
data on disease classification and epidemiology, as most 
of the patients could not be reliably classified by current 
classifications.
METHODS AND MATERIALS
The database of the University Hospital Regensburg 
contains 64 patients with a suspected diagnosis of MSL re-
corded between 2011 and 2017. From May to July 2017, all 
these patients were contacted (either called or sent a writ-
ten invitation) and invited to show up for clinical reevalu-
ation. Besides anamnesis, age, sex, weight, and height, 
assessment of comorbidities was prospectively recorded. 
Blood samples were taken, and the patients were clinically 
examined and photographed (with patient approval). For 
patients who could not or refused to show up, the same 
data were retrospectively collected from the database as 
present.
Diagnosis was clinically conducted by considering 
morphological characteristics and anamnesis. Morpho-
logical characteristics were defined as disproportionate 
hypertrophic symmetric fat tissue growth of MSL-typical 
areas. Anamnestic factors were the sudden occurrence 
of fat deposits that grew independently of general body 
fat increase and resistance to conservative therapies, 
such as diets. Based on the photographic documenta-
tion, 11 independent observers were asked to classify 
the patients according to the Donahuser classification 
(D). Furthermore, the body of every patient was subdi-
vided into 12 body areas. Chosen areas were neck, collar, 
shoulder girdle, upper arm, forearm, chest, abdomen, 
upper and lower back, hips, upper and lower limb. The 
observers evaluated which body parts were affected by 
MSL. Based on the frequency of every affected body 
area, we assessed which combinations of areas were af-
fected most frequently and set up a new classification 
based on these data.
By marking the postal codes of all patients on a map, 
a geographical area could be defined. From the local reg-
istration office, the population of the defined area was 
found. By dividing the population by the number of af-
fected patients, we could get an approximate prevalence 
of MSL in the area.
Ascertained blood values were electrolytes (Na2+, K+, 
Ca2+), creatinine, liver function reading (aspartate amino-
transferase [GOT], Alanine aminotransferase [GPT], gam-
ma-glutamyl transferase [gGT]), bilirubin, insulin, HBA1c, 
thyroid stimulating hormone (TSH), cholesterol, high-den-
sity lipoprotein (HDL) and low-density lipoprotein (LDL), 
and triglycerides were ascertained.
RESULTS
General
Of the 64 patients invited for reevaluation, only 26 
patients appeared to be clinically prospectively reeval-
uated. Prospectively collected data of these patients 
were family anamnesis, sudden disease occurrence, 
weight, height, blood samples, photographs, and co-
morbidities. Age of first presentation was collected 
retrospectively. Thirty-eight patients were completely 
retrospectively reevaluated out of the patient file. 
Three patients had already died. One patient died of 
cardiac failure; the causes of death of the other patients 
are unknown. In total, only 45 patients were correctly 
diagnosed with MSL following the criteria above. Mis-
diagnoses were lipedema (n = 3), lipomas (n = 3), lipo-
matosis dolorosa (n = 4), and obesity (n = 6). Figure 1 
shows an overview of the patient flow. Gender distribu-
tion was 13 (29%) males and 32 (71%) females (ratio 
m/f: 1/2.5). The mean age at the date of recording was 
55.5 (± 3) years (range, 27–78 years old). The mean 
weight was 91 kg (range, 53–130 kg), and mean height 
was 165.5 cm (range, 148–188 cm). The average body 
mass index was 33.2 kg/m2. The area obtained by mark-
ing the postal codes on a regional map, correspond to 
“Oberpfalz” in Bavaria, Germany, with a population of 
1,092,339. Prevalence was therefore calculated to be 
1:24,274. (Table 2).
Phenotyping
Photographs of 33 patients were assessed for pheno-
typing. Fallowing the Donhauser classification criteria, 
only 45% (n = 15) patients could be classified by the ob-
servers (Table 3). Affected body areas were collar in 3% 
of all patients (n = 1), neck in 64% (n = 21), shoulder 
girdle was affected in 36% (n = 12), upper arms in 48% 
(n = 16), forearms were not affected, chest was affected in 
33% (n = 11), and abdomen in 36% (n = 12). The upper 
back was affected in 30% (n = 10) and the lower back in 
Table 1. Donhauser Classification (D)7
Subtype Affected Body Areas
Type I (D) (horsecollar) Neck, upper back, shoulder girdle, 
and upper arms
Type II (D) (pseudo athletic 
type)
Shoulder girdle, deltoid region, 
upper arms, and thorax
Type III (D) (gynecoid type) Lower body, especially the thighs 
and medial side of the knees
Type IV (D) (abdominal type) Abdomen
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21% (n = 7). Hips and bottom showed MSL changes in 
52% (n = 17), upper legs were affected in 45% (n = 15), 
and only 3% of lower legs were affected (Fig. 2).
Most patients showed an affection of the 4 following 
areas: neck (64%), upper arms (48%), hips and bottom 
(52%), upper legs (45%). Of those with an affected shoul-
Fig. 1. Shows an overview of the patient flow.
Table 2.  General Characteristics of Our Patients
Characteristics Male Female All Patients
n (%) 13 (29) 32 (71) 45 (100)
Age (mean; ±3; y) 61 53.3 55.5
Weight (mean; kg) 90.5 85.5 91
Height (mean; cm) 174.5 162.3 165.5
BMI (mean; kg/m2) 29.7 32.6 33.2
Table 3. Comparison New Classification to Donhausers 
Classification (D) and Applicability on Our Patients
New  
Classification n (%) Donhauser Classification n (%)
Type I    
  Ia 3 Type I (D) (horsecollar) 3
  Ib 4 Type II (D) (pseudoathletic type) 1
  Ic 9   
Type II 11 Type III (D) (gynecoid type) 11
Type III 6  0
  Type IV (D) (abdominal type) 0
Total patients 
who could be 
classified
33 (100)  15 (45)
Fig. 2. Shows how often the different body areas are affected.
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der girdle, 57% of these also had an affected neck. Of those 
with affected upper arms, 62% of these also had an affected 
neck. Nearly half of all patients showed an affected chest 
and abdomen (48%). In contrast, of those patients with af-
fected neck or shoulder girdle, chest and abdomen, 69% 
and 63%, respectively, were affected in the upper arms. Fifty-
six percentage showed an affected upper back. Patients with 
affected hips and bottom showed an affection of the upper 
limb in 88% of cases. All patients suffering from affected up-
per legs showed affection of hip and bottom too.
When focusing on the number of affected areas per 
patient, only 3 patients (9%) showed only 1 affected area. 
In all 3 of them, only neck was affected. Twelve patients 
(36%) showed 2 affected areas. In these cases, 75% showed 
an affection of the hips/bottom and upper limbs and 25% 
an affection of neck and shoulder girdle. Seven patients 
(21%) showed 3 affected areas. Eighty-six percentage had 
an affection of the neck, shoulder girdle, and upper arms. 
Forty-three percentage showed in addition to neck and 
upper arms fat deposits on hips/bottom and 43% on the 
abdomen. Eleven patients (33%) showed more than 3 af-
fected areas. Most of them showed an affection of neck, 
upper arms, whole trunk, hips/bottom, and upper limb.
In general, one can say that in most cases either the 
upper body parts (type I; n = 16; 49%; neck, shoulder gir-
dle, upper arms, and trunk), the lower body parts (type 
II; n = 11; 33%; hips/bottom and upper legs) or a general 
distribution, apart from head, forearms, and lower legs 
are affected (type III; n = 6; 18%; Fig. 3A; Table 3).
The upper body part can be subdivided in type Ia 
(neck; n = 3; 9%), type Ib (neck + shoulder girdle + upper 
arms; n = 4; 12%) and type Ic (neck + shoulder girdle + up-
per arms + trunk; n = 9; 28%; Figs. 4–10; Table 4).
Fig. 3. Showing the different phenotypes of the new classification. 
a, phenotype i. B, phenotype ii. c, phenotype iii.
Fig. 4. Showing the different subtypes of type i (new classification). 
a, ia. B, ib. c, ic.
Fig. 5. Different phenotypes and subtypes and its distribution in our 
patients (%; new classification).
Fig. 6. patient suffering from MSl type ia (new classification).
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One female patient, presenting a phenotype type Ib, 
showed fat accumulation in the external labia as well. On 
demand, the patient stated that growth of the labia ap-
peared delayed to the other, more typical fat accumula-
tions. One female (type II) suffered additionally from a 
lipedema and lymphedema on both legs.
Comorbidities
Comorbidities were assessed through anamnesis and 
were obtained from all 45 patients. The most frequent co-
morbidities were hypercholesterolemia (n = 10) and hypo-
thyreosis (n = 9; Fig. 11). Fourteen patients (37%) had a 
positive family anamnesis of MSL. Twenty-one percentage 
(n = 8) of the patients consumed alcohol regularly, and 2 
patients admitted to suffering from alcohol abuse.
Blood Analysis
Blood samples were collected and analyzed from 30 
patients. The mean values are shown in Table 4. In total, 
one can say that results of the blood analyses were normal, 
besides a hypercholesterolemia (Table 5).
DISCUSSION
Of the 45 patients diagnosed with MSL (largest co-
hort in Germany so far), current phenotype classifica-
tions were mostly not applicable. According to current 
classifications, an affected abdomen does not occur in 
combination with the upper body part. In contrast, we 
found that when fat deposits occur in the abdominal 
area, it is always in combination with other parts of the 
upper body (new type Ic) or (new type III) a general dis-
tribution (46% of our patients). The general distribution 
type (new type III) that was found in 18% of our patients 
is not described in any current classification. The Don-
hauser classification7 is the most common classification, 
Fig. 7.  a and B, patient suffering from MSl type ib (new classification).
Fig. 8. a and B, patient suffering from MSl type ic (new classification).
Fig. 9. patient suffering from MSl type ii (new classification).
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set up in 1991 based on the clinical examination of 1 
single patient and descriptive data from the literature of 
previous case reports. It lacks a general distribution of fat 
deposits and the combination of upper arms, shoulders, 
thorax, and abdomen. In 55% (n = 18), the Donhauser 
classification was not applicable. Therefore, a new clas-
sification is needed. We tested the classification on our 
45 patients, and all of them corresponded to 1 of the 
defined types (Table 3). To validate the applicability of 
this classification, it has to be tested on a much larger 
number of patients and further studies must be done.
Recent studies have shown the presence of brown adi-
pose tissue in the neck of adults.18,19 Brown fat seems to 
play a role in the pathogenesis of MSL, as protein-1 mRNA, 
which is unique to brown fat, was found in resected fat tis-
sue from MSL patients.6,20 As the neck was affected in 64% 
of our patients and shows up in type Ia–c and type III, it 
might be possible that proliferation of MSL starts in the 
neck and spreads toward the lower body while progressing. 
Therefore, a structured and detailed anamnesis about the 
disease history of each patient has to be ascertained.
Patients who presented a phenotype type II often 
showed skin morphology as found in lipedema. Some-
Table 4. Overview of Phenotypes According to the New 
Classification
Phenotypes (New  
classification) Affected Body Areas
Type I Ia (Fig. 4) Neck
Ib (Fig. 5) Neck, shoulder girdle, upper arms
Ic (Fig. 6) Neck, shoulder girdle, upper arms, chest, 
abdomen, upper and lower back
Type II (Fig. 7) Hips, bottom, and upper legs
Type III (Fig. 8) General distribution skipping head, fore-
arms, and lower legs
Fig. 10. a–c, patient suffering from MSl type iii (new classification).
Fig. 11. Most common comorbidities in our MSl patients.
Table 5. Results of Blood Analysis (Mean Values)
 
Mean 
Value Range
Reference 
Value Unit
Sodium 140 127–144 136–145 mmol/L
Potassium 4.1 3.3–5.1 3.5–5.1 mmol/L
Calcium 2.2 0.95–3.23 2.12–2.52 mmol/L
Creatinine 0.9 0.56–1.79 0.67–1.17 mg/dL
GFR 72.8 28–147 50–100 ml/min/1.73q
GOT 24.6 12–56 < 50 U/L
GPT 20.9 8–37 < 50 U/L
Gamma-GT 77.8 14–252 < 60 U/L
Bilirubine (total) 0.8 0.26–2.56 0.2–1.0 mg/dL
HBA1c 5.4 4.8–5.95 4.8–5.9 %
Insuline 8.9 4.5–11.3 3.0–25.0 mU/L
TSH 2.2 0.79–6.58 0.35–3.74 mlU/L
Cholesterole 210.2+ 81–355 < 200 mg/dL
Triglycerides 98.0 31.3–370 < 150 mg/dL
HDL 61.0 44–123 40–60 mg/dL
LDL 124.9+ 42–193 < 100 mg/dL
GOT, aspartate aminotransferase; GPT, alanine aminotransferase; gGT, gamma-
glutamyl transferase; TSH, thyroid stimulating hormone; HDL, high-density 
lipoprotein; and LDL, low-density lipoprotein. Bold signifies diverge values.
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times it is difficult to distinguish lipedema from MSL 
type II. One criterion is that the hips and bottom are af-
fected, which are not affected in patients suffering from 
lipedema. Some patients may suffer from both, or from 
a mixed type.
The prevalence of MSL is indicated as 1:25,000 in 
the literature2–6 and refers to a clinical report from Italy 
in 1984.21 In the region of “Oberpfalz,” we found a simi-
lar prevalence of 1:24,274. However, the prevalence is 
considered to be higher, because there are expected to 
be many unknown cases. Without detailed epidemio-
logical research, this number cannot be projected on a 
larger population and should be seen as a regional prev-
alence. Furthermore, we found that contrary to most 
previous research, women (71%) are affected more of-
ten than men (29%; male:female ratio, 1:2.5). Plummer 
et al.20 also found a contrary male to female ratio of 1:6 
in a series of 7 patients. Thus, the exact value of the 
male:female ratio and its possible determinants of varia-
tions is an open issue.
Comorbidities found in our study agree with the 
comorbidities found in the literature. Hypercholes-
terinemia and hypothyroidism indicate a possible link 
to metabolic diseases. Hyperinsulinemia, neuropathy, 
and myopathy could not be found. However, patients 
were only interviewed about their comorbidities, with-
out individual examination. Some comorbidities might 
not have been assessed. Eight patients (21%) consumed 
alcohol regularly, but less than 24 g ethanol/d, and 2 
patients (5.3%) were suffering from alcohol abuse. 
Compared with the normal population in Bavaria, 
where 8.7% drink more than 24 g ethanol/d and 4.1% 
are suffering from alcohol abuse (Land Statistical Of-
fice, Germany 2012), a link to alcoholism in MSL could 
not be found. Blood analyses correspond to data from 
previous publications. Other than a manifest hypercho-
lesterinemia and some high TSH levels, blood values 
were found to be more or less normal.
As the only current therapies are liposuctions and sur-
gical lipectomy (with a high level of recurrence),22–26 fur-
ther research regarding pathogenesis is required. First, a 
systematic anamnestic study, to assess the exact age and 
area of first lipomatous occurrence, a possible evolution 
or progress of affected areas, family occurrence, eating 
and drinking habits, physical activity, psychological fac-
tors, desire for therapy, and postoperative satisfaction is 
highly desirable. Second, basic research on adipocytes 
from MLS tissue must be undertaken.
CONCLUSIONS
We set up a new, more precise classification that di-
vides phenotypes of MSL into 5 types (Ic, Ib, Ic, II, and 
III) based on the largest German cohort. Prevalence of 
MSL in central Europe must be considered higher than 
1:25,000. The male to female ratio was found to be 1:2.5 
(m:f). Hypercholesterinemia and hypothyroidism are fre-
quent comorbidities. Blood analyses are normal besides a 
hypercholesterinemia. A link to alcoholism could not be 
found. Pathogenesis of MSL remains unclear.
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